Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Calcitonin is a 32-amino acid peptide hormone that lowers blood calcium levels and inhibits bone resorption.1,2 The amino acid sequence of eel calcitonin varies from salmon (Item No. 24410) and human (Item No. 24409) calcitonin at 3 and 16 positions, respectively.3 Calcitonin (eel) binds to calcitonin receptor 2 (CTR2) with higher affinity than human, porcine, or rat calcitonin (Kis = 0.01, 2.95, 0.44, and 5.89 nM, respectively, in radioligand binding assays). It inhibits gastric emptying in conscious dogs more potently than human calcitonin when administered at a dose of 10 µg/kg.3,4 Calcitonin (eel) increases the paw withdrawal threshold in a mouse model of carrageenan-induced inflammation when administered at a dose of 0.2 µg/paw.5
WARNING This product is not for human or veterinary use.
1. Calcitonin. A review of experimental and clinical investigations. Postgrad. Med. J. 44(511), 411-422 (1968).
2. Salmon calcitonin: A review of current and future therapeutic indications. Osteoporos. Int. 19(4), 479-491 (2008).
3. Expression cloning and receptor pharmacology of human calcitonin receptors from MCF-
4. Gastrointestinal motor inhibition by exogenous human, salmon, and eel calcitonin in conscious dogs. Can. J. Physiol. Pharmacol. 73(1), 43-49 (1995).
5. Antinociceptive activity of eel calcitonin, injected into the inflamed paw in rats. Neuropharmacology 30(12A), 1275-1278 (1991).